Oncolytic, Virus

Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Veröffentlicht: 19.03.2026 um 23:36 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/oncolytic-virus-clinical-trial-landscape-gains-momentum-100-companies-lead-the-charge-in-pioneering-new-treatments--delveinsight-302678517.html

en | boerse | 68909057 |